Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Giant adrenal myelolipoma masquerading as heart failure.

Joy PS, Marak CP, Nashed NS, Guddati AK.

Case Rep Oncol. 2014 Mar 13;7(1):182-7. doi: 10.1159/000360981. eCollection 2014 Jan.

2.

Multiple-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Schmitt-Hoffmann A, Nyman L, Roos B, Schleimer M, Sauer J, Nashed N, Brown T, Man A, Weidekamm E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2576-80.

3.

Single-dose pharmacokinetics and safety of a novel broad-spectrum cephalosporin (BAL5788) in healthy volunteers.

Schmitt-Hoffmann A, Roos B, Schleimer M, Sauer J, Man A, Nashed N, Brown T, Perez A, Weidekamm E, Kovács P.

Antimicrob Agents Chemother. 2004 Jul;48(7):2570-5.

4.

Use of Monte Carlo simulations to select therapeutic doses and provisional breakpoints of BAL9141.

Mouton JW, Schmitt-Hoffmann A, Shapiro S, Nashed N, Punt NC.

Antimicrob Agents Chemother. 2004 May;48(5):1713-8.

5.

Scientific considerations of pharmaceutical solid polymorphism in abbreviated new drug applications.

Yu LX, Furness MS, Raw A, Outlaw KP, Nashed NE, Ramos E, Miller SP, Adams RC, Fang F, Patel RM, Holcombe FO Jr, Chiu YY, Hussain AS.

Pharm Res. 2003 Apr;20(4):531-6.

PMID:
12739758
6.

Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.

Botros SS, Makary EA, Ahmed KM, Ibrahim AM, Nashed NN, El-Nahal HM, Doughty BL, Hassanein HI.

Int J Immunopharmacol. 2000 Nov;22(11):979-88.

PMID:
11090706
7.

Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism.

Louis JM, Wondrak EM, Kimmel AR, Wingfield PT, Nashed NT.

J Biol Chem. 1999 Aug 13;274(33):23437-42.

8.

Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.

Louis JM, Dyda F, Nashed NT, Kimmel AR, Davies DR.

Biochemistry. 1998 Feb 24;37(8):2105-10.

PMID:
9485357
9.

A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation.

Wondrak EM, Nashed NT, Haber MT, Jerina DM, Louis JM.

J Biol Chem. 1996 Feb 23;271(8):4477-81.

10.

Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein.

Louis JM, Nashed NT, Parris KD, Kimmel AR, Jerina DM.

Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7970-4.

11.

Polyamine-like actions of peptides derived from conantokin-G, an N-methyl-D-aspartate (NMDA) antagonist.

Chandler P, Pennington M, Maccecchini ML, Nashed NT, Skolnick P.

J Biol Chem. 1993 Aug 15;268(23):17173-8.

12.

Isolation of Batai virus (Bunyaviridae:Bunyavirus) from the blood of suspected malaria patients in Sudan.

Nashed NW, Olson JG, el-Tigani A.

Am J Trop Med Hyg. 1993 May;48(5):676-81.

PMID:
8517485
13.

An air-gap enzyme electrode: development and applications.

Shanker RM, Nashed NE, Lindenbaum S.

Pharm Res. 1992 Apr;9(4):485-91.

PMID:
1495893
14.

A leucine zipper-like motif may mediate HIV reverse transcriptase subunit binding.

Baillon JG, Nashed NT, Kumar A, Wilson SH, Jerina DM.

New Biol. 1991 Oct;3(10):1015-9. No abstract available.

PMID:
1722701
15.

Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli.

Louis JM, McDonald RA, Nashed NT, Wondrak EM, Jerina DM, Oroszlan S, Mora PT.

Eur J Biochem. 1991 Jul 15;199(2):361-9.

16.

Free-living amoebae in Egypt. 1. Naegleria gruberi and Naegleria fowleri.

Nashed NN, Youssef FG, Mansour NS.

J Egypt Soc Parasitol. 1991 Apr;21(1):31-42.

PMID:
2033306
17.

Fresh-water amoebae from four aquatic sites in Egypt.

Mansour NS, Saoud AF, Nashed NN, Youssef FG.

J Egypt Soc Parasitol. 1991 Apr;21(1):15-22.

PMID:
2033288
19.

Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV.

Nashed NT, Louis JM, Sayer JM, Wondrak EM, Mora PT, Oroszlan S, Jerina DM.

Biochem Biophys Res Commun. 1989 Sep 15;163(2):1079-85.

PMID:
2551268
20.

Construction, characteristics and application of a benzene-1,2,4-tricarboxylic acid selective electrode.

Nashed NE, Lindenbaum S.

Analyst. 1987 Feb;112(2):205-7. No abstract available.

PMID:
3578823
21.

7-Dehydrocholesterol 5,6 beta-oxide as a mechanism-based inhibitor of microsomal cholesterol oxide hydrolase.

Nashed NT, Michaud DP, Levin W, Jerina DM.

J Biol Chem. 1986 Feb 25;261(6):2510-3.

22.

Properties of liver microsomal cholesterol 5,6-oxide hydrolase.

Nashed NT, Michaud DP, Levin W, Jerina DM.

Arch Biochem Biophys. 1985 Aug 15;241(1):149-62.

PMID:
4026314
23.
24.

Thionesters as a probe for electrophilic catalysis in the serine protease mechanism.

Campbell P, Nashed NT, Lapinskas BA, Gurrieri J.

J Biol Chem. 1983 Jan 10;258(1):59-66.

25.
26.

The mutagenicity-enhancing effect of glucose.

Nashed N.

Mutat Res. 1981 May;91(3):213-4. No abstract available.

PMID:
7242551
27.

An in vivo-in vitro short term carcinogenicity test using rat peritoneal cells.

Nashed N, Chandra P.

Cancer Lett. 1980 Aug;10(2):95-107.

PMID:
7459837
29.
30.

Hybrid cell proposed.

Nashed N.

Science. 1974 Dec 27;186(4170):1159. No abstract available.

PMID:
17833916
31.

A lack of noncomplementation among chemically induced ad2 mutants of Saccharomyces cerevisiae.

Nashed N.

Mol Gen Genet. 1968;102(4):348-52. No abstract available.

PMID:
5743436
32.
33.

[On the nature of dominance in the ad2 locus of Saccharomyces cerevisiae].

Nashed N.

Mol Gen Genet. 1968;102(4):285-9. No abstract available.

PMID:
5743431
34.

Negative complementation among ad2 mutants of yeast.

Nashed N, Jabbur G, Zimmermann FK.

Mol Gen Genet. 1967;99(1):69-75. No abstract available.

PMID:
5586534
35.
36.

[Carcinogenic alkylating substances. I. Dimethylsulfate, carcinogenic action in rats and probable cause of occupational cancer].

Druckrey H, Preussmann R, Nashed N, Ivankovic S.

Z Krebsforsch. 1966;68(1):103-11. German. No abstract available.

PMID:
4228031

Supplemental Content

Loading ...
Support Center